Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Glyoxal Market worth $326 million by 2024

 



(PharmaNewsWire.Com, December 04, 2020 ) The report "Glyoxal Market by Application (Crosslinking, Intermediate), End-Use Industry (Textile, Paper, Derivatives, Oil & Gas, Cosmetic/Personal Care, Leather), Region (North America, Europe, APAC, Middle East & Africa, South America) - Global Forecast to 2024", is projected to grow from USD 265 million in 2019 to USD 326 million by 2024, at a CAGR of 4.3%.

Download PDF brochure of the Report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209953364

Increasing demand for textiles owing to the growth of the global population and rising consumer disposable income in emerging economies is propelling the global glyoxal market growth. Additionally, increasing use of glyoxal as an intermediate in agriculture, pharmaceutical, and chemical industries to derive different organic molecules is also propelling the demand for glyoxal.

Crosslinking segment is projected to lead the glyoxal market during the forecast period

Crosslinking is expected to be the largest application of glyoxal during the forecast period. The organic compound is a formaldehyde-free agent with thermal stability. As a crosslinker, glyoxal is compatible with different kinds of fibers, including cellulose and starch, among others. Moreover, the crosslinking application of glyoxal is useful in the textile industry to increase crease resistance of fibers; in the paper industry to reduce water absorption capacity; in the leather industry to improve durability; and in the cosmetics industry to increase the viscosity of the emulsion.

Derivatives industry is projected to register the highest CAGR during the forecast period.

Based on end-use industry, derivatives is projected to register the highest CAGR between 2019 and 2024. The use of glyoxal is increasing due to its versatility, making it suitable for a wide range of organic molecules. Glyoxal is suitable to derive glyoxylic acid, which is further used to manufacture agrochemicals. In addition, glyoxal aids in the formulation of numerous medicines, including antibiotics, disinfectants, and others. The aging population and increased risk of non-communicable disease resulting in driving the demand for pharmaceutical products, and rapid industrialization increases consumption of a variety of chemicals. All the factors mentioned above together drive the global glyoxal market growth.

Don't miss out on business opportunities in Glyoxal Market. Speak to Our Analyst and gain crucial industry insights that will help your business grow. https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=209953364

Browse in-depth TOC on "Glyoxal Market”
107 - Market Data Tables
34 - Figures
129 - Pages

APAC is projected to register the highest CAGR between 2019 and 2024

The glyoxal market in APAC has immense growth potential driven by the increasing demand for textiles and chemicals. China, India, Vietnam, and Japan are some of the key markets in the region. The expansion of the industrial base in these countries is expected to fuel industry growth over the forecast period.

BASF SE (Germany), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), WeylChem International GmbH (Germany) and Haihang Group (China) are some of the leading players with a substantial glyoxal market share in 2018. Investment & expansion and merger & acquisition were the major growth strategies adopted by the market players between 2014 and 2018 to enhance their regional footprint and meet the growing demand for Glyoxal in the emerging economies.

Get This Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=209953364

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


MarketsandMarkets™

Mr. Aashish Mehra

1-888-600-6441

raviraj.tak@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC